Companion Animal Health Market Research Report - Global Forecast to 2025 - Cumulative Impact of COVID-19
SKU : MRR-C794B3F | Publication Date : October 2020
SKU : MRR-C794B3F | Publication Date : October 2020
The Global Companion Animal Health Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the Global Companion Animal Health Market.
Market Segmentation & Coverage:
The research report categorizes the Companion Animal Health Market to forecast the revenues and analyze the trends in each of the following segments:
Based on Animal, the Companion Animal Health Market studied across Cats, Dogs, and Horses.
Based on Indication, the Companion Animal Health Market studied across Behavioral Disorders, Dental Diseases, Dermatologic Diseases, Infectious Diseases, and Orthopedic Diseases.
Based on Type, the Companion Animal Health Market studied across Medicinal Additive Feed, Nutritional Feed Additives, Pharmaceuticals, and Vaccines. The Medicinal Additive Feed further studied across Amino Acids, Minerals, and Vitamins. The Nutritional Feed Additives further studied across Enzymes, Feed Acidifiers, Hormones, Immune Modulators, and Prebiotics & Probiotics. The Pharmaceuticals further studied across Anti-inflammatories, Antibiotics, Ectoparasiticides, and Endoparasiticides.
Based on End User, the Companion Animal Health Market studied across Retail Pharmacies and Veterinary Hospitals.
Based on Geography, the Companion Animal Health Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
The factors attributing to the growth of the market are increasing online shopping and home delivery is driving the product sale, changing the perception of the consumers toward pet health and longer life expectancy for companion animal, increasing disposable incomes and pet owners afford to spend more on pet healthcare, technological advancements in the field of animal healthcare, and increasing initiatives by government and animal welfare associations. However, some factors such as lack of infrastructure, funding, and standardization and increase in cheap counterfeit drugs may hinder the market growth. The Companion Animal Health Market expected to showcase the opportunities such as lack of infrastructure, funding, and standardization and increase in cheap counterfeit drugs. Soon market may face the possible challenges in the growth due to high cost associated with animal testing and veterinary in developing countries and prohibition on the use of antibiotics and antimicrobials in animal feed in many countries,. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the market.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Companion Animal Health Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Company Usability Profiles:
The Companion Animal Health Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increased competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Companion Animal Health Market, including Aratana Therapeutics, Inc., Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale S.A., Dechra Pharmaceuticals PLC, Elanco US, Inc., Eli Lilly and Company, Merck & Co., Inc., Nutreco N.V., Vetoquinol SA, Virbac SA, and Zoetis, Inc..
List of Tables
List of Figures